Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations

Fig. 2

Prevalence of NOPs in IN genes from CRF02_AG subtypes. The figure shows the distribution of variants among the 287 and 20 CRF02_AG full length integrase sequences. Divided into: N-terminal domain (NTD) (residues 1–50), catalytic core domain (CCD) (residues 50–212) and C-terminal domain (CTD) composes of amino acids 213–288

Back to article page